bioRxivCancer Biology
WILMS TUMORIGENESIS IN HUMAN KIDNEY ORGANOIDS
Abstract
The loss or failure of cell differentiation is a hallmark of cancer, yet whether perturbation of differentiation is causal or consequential to malignant transformation is largely unclear. Wilms tumor is the most widespread kidney cancer in children. Here, we establish a model for Wilms tumorigenesis in human kidney organoids. We show that loss of the tumor suppressor WT1 during organoid formation induces overgrowth of kidney progenitor cells at the expense of differentiating tubules. Functional and gene expression analyses demonstrate that absence of WT1 halts progenitor cell progression at a pre-epithelialized cell state and recapitulates the transcriptional changes detected in a subgroup of Wilms tumor patients with ectopic myogenesis. By "transplanting" WT1 mutant cells into wild-type kidney organoids, we find that their propagation requires an untransformed microenvironment. Genetic engineering of cancer lesions in human organoids therefore permits phenotypic modeling of tumor initiation and progression, and complements the current toolbox of pre-clinical Wilms tumor models.
- organism: human
- assay: organoid / primary culture
- research focus: cell type annotation
- research focus: differential expression
- research focus: transcription & RNA processing
- approach: experimental assay
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genotype-phenotype correlations and de novo induction of cancer stem cells in Wilms tumor initiation.
N.S. Pop, Daniëlle Koot, … Peter Hohenstein·bioRxiv·Nov 19, 2025
- Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early stem cell origin
B. Royer-Pokora, W. Wruck, M. Beier·bioRxiv·Jun 10, 2022
- Exploiting Embryonic Niche Conditions to Grow Wilms Tumor Blastema in Culture
H. Wojcik, H. N. Lovvorn, … A. O. Perantoni·Frontiers in OncologyPeer-reviewed·Mar 16, 2023
- Podocyte lineage marker expression is preserved across Wilms tumor subtypes and enhanced in tumors harboring the SIX1/2 p.Q177R mutation
M. J. Stevenson, S. K. Phanor, … L. L. O'Brien·bioRxiv·Nov 2, 2022
- Mice with renal-specific alterations of stem cell-associated signaling develop symptoms of chronic kidney disease but surprisingly no tumors
A. Myszczyszyn, O. Popp, … W. Birchmeier·bioRxiv·Feb 28, 2023
- An engineered tumor organoid model reveals cellular identity and signaling trajectories underlying translocation RCC.
M. Ganpat, F. Morales-Rodriguez, … J. Drost·bioRxiv·Sep 1, 2023